New Osia® OSI200 active transcutaneous bone-anchored hearing device: how I do it

Chew, Dylan; Proctor, Vicki; Ray, Jaydip

doi:10.1007/s00405-022-07786-w

Cited by 6 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Initial studies from implantation of the new Osia BCHA system reported postoperative complications such as skin dehiscence and infection (often requiring removal), hematoma, and intraoperative dural exposure 11,14–16 . Due to this, modifications in surgical technique have been reported with an attempt to decrease wound complications, improve aesthetics, and increase the ease of the procedure 17,19 . The present report details similar modifications and provides surgical characteristics and outcomes.…”

Section: Discussionmentioning

confidence: 85%

“…11,[14][15][16] Due to this, modifications in surgical technique have been reported with an attempt to decrease wound complications, improve aesthetics, and increase the ease of the procedure. 17,19 The present report details similar modifications and provides surgical characteristics and outcomes. Results show that the modified technique is a safe and effective method for implantation of the transcutaneous BCHA system with a low complication rate.…”

Section: Discussionmentioning

confidence: 94%

See 1 more Smart Citation

Surgical Outcomes of Modified Technique for Transcutaneous Bone Conduction Hearing Aid Implantation

Hicks,

Brown,

Selleck

et al. 2023

The Laryngoscope

View full text Add to dashboard Cite

ObjectiveTo detail a modified surgical technique for implantation of the Osia 2 Bone Conduction Hearing Aid (BCHA) system and to assess intra‐ and postoperative outcomes of this technique.MethodsA retrospective review was performed for cases undergoing implantation of an Osia 2 BCHA at a tertiary academic medical center. Modifications were made to the surgical procedure including: horizontal or curvilinear incisions, placement of the osseointegrated screw slightly superior to the plane of the external auditory canal, and double layer wound closure. Data regarding outcomes including demographics, incision type, surgical time, drilling requirements, and complications were collected using the electronic medical record.ResultsA total of twenty‐eight cases were evaluated with 57.1% and 42.9% utilizing horizontal and curved incisions, respectively. The median age for recipients was 43.1 years with six pediatric cases included in the study. Median operative time was 58 min (43–126 min). The majority of cases required minimal (60.7%) or no drilling (28.6%) with a significant increase in operative time for those requiring moderate drilling versus minimal to no drilling (F = 8.02, p = 0.002). There were no intraoperative complications. One (3.6%) postoperative seroma occurred which resolved with conservative management.ConclusionThe proposed modified surgical technique is a safe and effective method for implantation of the transcutaneous BCHA system with a low complication rate. Keys include incision design, implant placement, and two‐layered closure to minimize wound tension. These modifications can improve ease of the procedure and reduce operative time. These techniques also appear to be applicable to the pediatric population.Level of EvidenceIII Laryngoscope, 2023

show abstract

Section: Discussionmentioning

confidence: 85%

Section: Discussionmentioning

confidence: 94%

Surgical Outcomes of Modified Technique for Transcutaneous Bone Conduction Hearing Aid Implantation

Hicks,

Brown,

Selleck

et al. 2023

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…Future prospective studies targeting patients under 12 years of age are certainly warranted. Additionally, these can compare the BCI 602 to other transcutaneous implants for this group of patients 40,41 …”

Section: Discussionmentioning

confidence: 99%

“…Additionally, these can compare the BCI 602 to other transcutaneous implants for this group of patients. 40,41 The optimized geometry of the BCI 602 should facilitate implantation in patients with challenging anatomical conditions or with a cortical bone thickness from 4.5 mm. 10,13 Nevertheless, dura was exposed in certain cases.…”

Section: Surgical Outcomesmentioning

confidence: 99%

Early Results With the New Active Bone‐Conduction Hearing Implant: A Systematic Review and Meta‐Analysis

Lein,

Baumgartner,

Riss

et al. 2024

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

ObjectiveThe bone conduction implant (BCI) 602 is a new transcutaneous BCI with smaller dimensions. However, limited patient numbers restrict the statistical power and generalizability of the current studies. The present systematic review and meta‐analysis summarize early audiological and medical outcomes of adult and pediatric patients implanted with the BCI 602 due to mixed or conductive hearing loss.Data SourceFollowing the Preferred Reporting items for Systematic Reviews and Meta‐analyses guidelines, 108 studies were reviewed, and 6 (5.6%) were included in the meta‐analysis.Review MethodThe data on study and patient characteristics, surgical outcomes, and audiological test results were extracted from each article. Meta‐analysis employed the fixed‐effect and random‐effects models to analyze the mean differences (MDs) between pre‐ and postoperative performances.ResultsIn total, 116 patients were evaluated, including 64 (55%) adult and 52 (45%) pediatric patients. No intraoperative adverse events were reported, while postoperative complications were reported in 2 (3.1%) adult and 2 (3.8%) pediatric patients. Studies consistently showed significant improvements in audiological outcomes, quality of life, and sound localization in the aided condition. In the meta‐analysis, we observed a significant difference in the unaided compared to the aided condition in sound field thresholds (n = 112; MD, −27.05 dB; P < 0.01), signal‐to‐noise ratio (n = 96; MD, −6.35 dB; P < 0.01), and word recognition scores (n = 96; MD, 68.89%; P < 0.01).ConclusionThe implantation of the BCI 602 was associated with minimal surgical complications and excellent audiological outcomes for both the pediatric and the adult cohort. Therefore, our analysis indicates a high level of safety and reliability. Further research should focus on direct comparisons with other BCIs and long‐term functional outcomes.

show abstract

Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study

Jukic,

Cismas,

Flores

et al. 2024

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

ObjectiveThe purpose of this study was to review patient demographics, indications, intraoperative findings, complications/adverse events, and audiological outcomes related to the implantation of the Osia 2 device.Study DesignRetrospective case series.SettingSingle tertiary institutional experience.MethodsPatients who had undergone Osia 2 implantation by the senior author were identified from 2019 to present. Information was extracted from patient charts concerning patient demographics, indications for implantation, surgical findings, audiological outcomes, and adverse events.ResultsSixty patients and 67 implants were included. The median age was 51 years (R: 11‐92). Fifty‐five percent of patients had mixed hearing loss (HL), 30% had single‐sided deafness, and 15% had conductive HL. The mean operative time was 53.9 minutes. Only 4.5% of patients required bone polishing, and 3.0% required tissue thinning. The mean pure‐tone averages 4 gain from unaided conditions was 41.2 dB. Mean gain at 6 and 8 kHz from unaided conditions was 35.42 and 40.67 dB, respectively. Mean improvement in speech recognition threshold and word recognition score was significant in noise and quiet conditions. The all‐cause adverse event/complication rate in our series was 10.4%. The most common complications were infections (4.5%) and poorly controlled postoperative pain (3.0%). Hematomas occurred in 1.5% of patients. Reoperation was required in 4 patients; explant in 1.ConclusionUse of the Osia 2 device in our series has resulted in good hearing outcomes, particularly in terms of high frequency gain. Complication rates were low. To our knowledge, this is the largest study to date reporting on Osia 2 outcomes.

show abstract

New Osia® OSI200 active transcutaneous bone-anchored hearing device: how I do it

Cited by 6 publications

References 9 publications

Surgical Outcomes of Modified Technique for Transcutaneous Bone Conduction Hearing Aid Implantation

Surgical Outcomes of Modified Technique for Transcutaneous Bone Conduction Hearing Aid Implantation

Early Results With the New Active Bone‐Conduction Hearing Implant: A Systematic Review and Meta‐Analysis

Clinical Outcomes of an Active, Transcutaneous, Bone Conduction Hearing Device: A Retrospective Study

Contact Info

Product

Resources

About